mevastatin has been researched along with Melanoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clynes, M; Eustace, AJ; Glynn, SA; O'Donovan, N; O'Sullivan, D | 1 |
| Melnykovych, G; Ramachandran, CK; Sanders, K | 1 |
2 other study(ies) available for mevastatin and Melanoma
| Article | Year |
|---|---|
The 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors, simvastatin, lovastatin and mevastatin inhibit proliferation and invasion of melanoma cells.
Topics: Apoptosis; Breast Neoplasms; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Proliferation; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Lovastatin; Lung Neoplasms; Male; Melanoma; Neoplasm Invasiveness; Simvastatin; Skin Neoplasms | 2008 |
Enhancement in the adhesion of tumor cells to endothelial cells by decreased cholesterol synthesis.
Topics: Animals; Anticholesteremic Agents; Cattle; Cell Adhesion; Cells, Cultured; Cholesterol; Dexamethasone; Endothelium; Hydroxycholesterols; Ketocholesterols; Lovastatin; Melanoma; Membrane Fluidity; Membrane Lipids; Mice; Microscopy, Electron, Scanning; Naphthalenes; Retinoids | 1986 |